| Literature DB >> 29391996 |
Özlem Ünsal1, Bilge Türk1, Meltem Akpınar1, Mustafa Bağlı1, Berna Uslu Coşkun1.
Abstract
Squamous cell carcinoma of the larynx is rarely encountered in HIV (human immunodeficiency virus)-positive patients compared with HIV-associated malignancies. Standard protocols are absent for the management of laryngeal carcinoma in HIV-positive patients. HIV infection-associated immune suppression increases the mortality and morbidity of laryngeal carcinoma treatment. In the management of laryngeal carcinoma in HIV-positive patients, beside the clinical staging, the detection of CD4+ cell count is important. Regular antiretroviral treatment may have favorable effects in the management of laryngeal carcinoma. The treatment modality in the presented HIV-positive case with the diagnosis of laryngeal cancer was determined with a multidisciplinary approach.Entities:
Keywords: HIV; Laryngeal cancer; immunodeficiency; retrovirus; treatment
Year: 2015 PMID: 29391996 PMCID: PMC5782918 DOI: 10.5152/tao.2015.839
Source DB: PubMed Journal: Turk Arch Otorhinolaryngol ISSN: 2667-7466